Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024
18 Luglio 2024 - 10:05PM
Business Wire
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the
Company will provide financial results for the second quarter ended
June 30, 2024, on August 1, 2024. The Company will host a
conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
on August 1, 2024.
Financial results will be provided via a press release after
market close and will be accessible under Press Releases in the
Investors section of the Vir website at www.vir.bio. Participants
may access the conference call via webcast on the Events &
Presentations page of Vir’s website at
https://investors.vir.bio/events-presentations or listen in by
dialing the U.S. toll free number (800) 715-9871 or international
+1 (646) 307-1963, Conference ID: 7568777. A recorded version of
the call will be available on the website approximately two hours
after the completion of the event and will be archived there for 30
days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is an immunology company focused on
powering the immune system to transform lives by treating and
preventing infectious diseases and other serious conditions,
including viral-associated diseases. Vir has assembled two
technology platforms that are designed to modulate the immune
system by exploiting critical observations of natural immune
processes. Its current clinical development pipeline consists of
product candidates targeting hepatitis delta and hepatitis B
viruses, and human immunodeficiency virus. Vir has several
preclinical candidates in its pipeline, including those targeting
influenza A and B, COVID-19, RSV/MPV and HPV. Vir routinely posts
information that may be important to investors on its website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240718400254/en/
Media Carly Scaduto Senior Director, External
Communications cscaduto@vir.bio +1 314-368-5189
Investors Richard Lepke Senior Director, Investor
Relations rlepke@vir.bio +1 978-973-9986
Grafico Azioni Vir Biotechnology (NASDAQ:VIR)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Vir Biotechnology (NASDAQ:VIR)
Storico
Da Dic 2023 a Dic 2024
